Leyenda:
	National REC
	Institutional REC

Esta página aún no tiene información.

Heath Research Web is a public platform for information on research for health and development, it depends on contributions and participation from all who are interested in promoting health, health equity and development.

Please help Ghana populate its page

1

Escoja su perfil de usuario

2

Cree su cuenta

3

Active su cuenta

4

Empiece a usar HRWeb

Documento
Ghana National Drug Policy (Second Edition) July 2004 This document is the second edition of the National Drug Policy prepared by the Ministry of Health of Ghana in 1998. The revision was based on the second Programme of Work of the Ministry of Health, the World Health Organisation?s guidelines for drug policy development and implementation and recent developments in World trade, including Trade-Related Aspects of Intellectual Property Rights (TRIPS) Agreement and its Public Health Safeguards. These reflect concerns raised regarding access to medicines for managing existing and emerging diseases of public health importance such as HIV/AIDS, tuberculosis malaria and buruli ulcer. The policy document is to guide the pharmaceutical sector in Ghana. The various elements examined under the policy include, legislation and regulatory control, drug registration, selection of essential drugs, local manufacture, herbal medicines, drug procurement and supply management, quality assurance, co-ordination, monitoring and evaluation. In highlighting these areas, due cognizance has been given to available resources, potential of drugs in disease management and the socio-economic environment. The policy has also been formulated with an inherent flexibility to accommodate future developments and changes in the overall vision of attaining health for all.

Documento

Ghana National Drug Policy (Second Edition) July 2004
This document is the second edition of the National Drug Policy prepared by the Ministry of Health of Ghana in 1998. The revision was based on the second Programme of Work of the Ministry of Health, the World Health Organisation?s guidelines for drug policy development and implementation and recent developments in World trade, including Trade-Related Aspects of Intellectual Property Rights (TRIPS) Agreement and its Public Health Safeguards. These reflect concerns raised regarding access to medicines for managing existing and emerging diseases of public health importance such as HIV/AIDS, tuberculosis malaria and buruli ulcer. The policy document is to guide the pharmaceutical sector in Ghana. The various elements examined under the policy include, legislation and regulatory control, drug registration, selection of essential drugs, local manufacture, herbal medicines, drug procurement and supply management, quality assurance, co-ordination, monitoring and evaluation. In highlighting these areas, due cognizance has been given to available resources, potential of drugs in disease management and the socio-economic environment. The policy has also been formulated with an inherent flexibility to accommodate future developments and changes in the overall vision of attaining health for all.

Documento
Navronga Consent Form Checklist (pdf, 19.15 Kb)

Esta página aún no tiene información.

Heath Research Web is a public platform for information on research for health and development, it depends on contributions and participation from all who are interested in promoting health, health equity and development.

Please help Ghana populate its page

1

Escoja su perfil de usuario

2

Cree su cuenta

3

Active su cuenta

4

Empiece a usar HRWeb

Esta página aún no tiene información.

Heath Research Web is a public platform for information on research for health and development, it depends on contributions and participation from all who are interested in promoting health, health equity and development.

Please help Ghana populate its page

1

Escoja su perfil de usuario

2

Cree su cuenta

3

Active su cuenta

4

Empiece a usar HRWeb